SCHEMBL8613591

SCHEMBL8613591

CCC[C@H](C)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290488 1.00
SCHEMBL23767390 1.00
SCHEMBL11772804 0.85 ACE2 (0.48)
SCHEMBL9163435 0.84
SCHEMBL1409399 0.84
SCHEMBL1410433 0.82 CA1 (0.61)
SCHEMBL1409670 0.80 CA1 (0.59)
SCHEMBL2487690 0.80 CA1 (0.59)
SCHEMBL9405814 0.80 CA1 (0.59)
SCHEMBL8020771 0.80 CA1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2763969-B1 ETHYNYL DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS HOFFMANN LA ROCHE (CH) 2015-11-25 EP disclosed
EP-2763969-A1 ETHYNYL DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS F.HOFFMANN-LA ROCHE AG (CH) 2014-08-13 EP disclosed
US-8530472-B2 Ethynyl derivatives HOFFMANN-LA ROCHE INC. (US) 2013-09-10 US disclosed
WO-2013050460-A1 ETHYNYL DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2013-04-11 WO disclosed
US-20130090347-A1 ETHYNYL DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2013-04-11 US disclosed
US-7160880-B1 Short-acting benzodiazepines CENES LIMITED (GB) 2007-01-09 US disclosed
US-5827855-A ANTICHOLESTEROL AGENTS TREATING CARDIOVASCULAR DISORDERS; ENZYME INHIBITORS SANKYO COMPANY, LIMITED (JP) 1998-10-27 US disclosed
US-5451688-A Inhibit biosynthesis of cholesterol SANKYO COMPANY, LIMITED (JP) 1995-09-19 US disclosed
EP-0605230-A1 Hexanhydronaphthalene ester derivatives, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1994-07-06 EP disclosed